Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 60 of the 63 references it cites were found in a registry or an index, and 3 are not checked yet; none of the 83 sources its claims cite is checked for support yet.

Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development

Open access
Olivieri, Cristina, Wu, Jian, Taylor, Susan S., Veglia, Gianluigi · 2025 · Current Opinion in Structural Biology

Abstract

Protein kinases catalyze the transfer of phosphate groups from ATP to specific substrates, initiating, modulating, or terminating signaling cascades. Generally, the response of these enzymes to stimuli is characterized by ultrasensitive rather than graded responses and mediated by cooperative binding interactions. Here, we provide examples of positive and negative cooperativity processes regulating several protein kinases. We first examine the binding cooperativity between nucleotide and substrate in protein kinase A, showing how dysfunctional cooperativity may be linked to signalopathies. We then illustrate how certain drugs exploit cooperativity to inhibit kinase homo- and hetero-dimerization or select for active and inactive conformational states. A molecular understanding of binding cooperativity could lead to the development of new kinase-specific inhibitors, opening up novel therapeutic possibilities.

Checked 2026-11-17 · 3 references not checked yet

Overview

CoChat Summary

TL;DR

This review argues that positive and negative allosteric binding cooperativity between nucleotide, substrate, and regulatory sites controls kinase signaling, and that its disruption contributes to signalopathies and cancer. It surveys examples from PKA, Src, BRAF, PDK1, Cdk2, and others to suggest that ATP-competitive inhibitors can be designed to tune substrate binding and conformational states.

Key findings

  • In PKA-C, ATP binding positively cooperates with substrate binding, while ADP and phosphorylated substrate show negative cooperativity; CHESCA maps show a dense allosteric network for wild-type PKA-C and sparse correlations for negative cooperativity. Mutations Y204A, F100A, L205R, E31V and the DNAJB1-PRKACA chimera reduce or abolish cooperativity and are linked to Cushing’s syndrome, cancers, and fibrolamellar hepatocellular carcinoma.
  • Other kinases show distinct cooperativity patterns: eEF-2K has positive cooperativity with ADP and calmodulin; Src shows negative cooperativity among ATP and substrates but positive cooperativity among products, also observed in Abl and Hck; BRAF type II inhibitors cause asymmetric allosteric coupling linked to paradoxical activation; PDK1 shows positive cooperativity for adenosine/substrate but negative for PS653; selective Cdk2 inhibitors show negative cooperativity with cyclin.
  • ATP-competitive inhibitors can allosterically modulate substrate affinity: balanol retains substrate binding while H89 shows negative cooperativity, and NMR-derived methyl order parameters/conformational entropy linearly correlate with cooperativity coefficients. The paper notes 85 FDA-approved small molecule drugs directly target kinases, with five new drugs expected between 2024 and 2025, and cites asciminib as targeting the ABL myristoyl-binding site.

Methods

  • Review article; no primary experimental design, data, or sample is stated in the paper.
  • Main analysis is a narrative synthesis of cited structural, thermodynamic, and computational studies, including NMR CHESCA, ITC, methyl order parameters, molecular dynamics, DEER, FRET, 19F NMR, and HDX-MS.
  • Sample size and statistical analysis: Not stated in the paper.

Limitations

  • Stated: the molecular mechanisms behind signal amplification, attenuation, or disruption due to cooperative ligand binding are still poorly understood; there are no established principles guiding rational design of highly selective kinase inhibitors; kinase signaling complexity is accentuated by isoform specificity.
  • Evident: as a review, it presents selected examples rather than a systematic review or meta-analysis and reports no new primary data; many mechanistic claims depend on cited studies not fully detailed in the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.sbi.2025.103169

Cites

60 of 63 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 1 Not valid · 67 Not checked · 12 Own results and interpretations

43 more claims

Create a free account to see all 80 claims and to verify the 83 references still open.

See all claims — free account
  • It may state two separate claims as one. 28
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Citations

Cites

Show all 60 references

Cited by

See all 1

Metadata

Authors
Olivieri, C., Wu, J., Taylor, S. S., & Veglia, G.
Affiliations
  • University of Minnesota (US)
  • University of California San Diego (US)
Corresponding author
  • Taylor, Susan S.
  • Veglia, Gianluigi
Venue
Current Opinion in Structural Biology
Publisher
Elsevier BV
Published
2025-12
Volume
95
Pages
103169
ISSN
0959-440X (ISSN-L)
OpenAlex
W4415233356
Cited by
1
References
60
Citations by year
2026: 1
FWCI
0.07
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Structural Biology (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIGMS (GM130389)
  • National Institutes of Health
  • NCI (CA290129)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
protein kinases, signal transduction, protein kinase A, kinase inhibitors, kinase dimerization, ATP binding, substrate binding
MeSH terms
Drug Development, Allosteric Regulation, Animals, Humans, Protein Binding, Protein Kinases, Signal Transduction, Protein Kinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development. https://app.cochat.ai/papers/10.1016/j.sbi.2025.103169
The paper
Olivieri, C., Wu, J., Taylor, S. S., & Veglia, G. (2025). Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development. Current Opinion in Structural Biology. https://doi.org/10.1016/j.sbi.2025.103169

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.